# Lars Wallentin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-wallentin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 119,631 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 147 |
| i10-index | 605 |
| Last Known Institution | Uppsala University |
| OpenAlex ID | https://openalex.org/A5063591215 |
| ORCID iD | https://orcid.org/0000-0003-0378-6531 |
| Works | 1,161 |

## Researcher papers

Showing 12 of 14.

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/ticagrelor-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [Third universal definition of myocardial infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction-3/)
- [Third Universal Definition of Myocardial Infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction/)
- [Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction](https://scholariq.org/papers/universal-definition-of-myocardial-infarction-kristian-thygesen-joseph-s-alpert/)
- [Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials](https://scholariq.org/papers/platelet-glycoprotein-iib-iiia-inhibitors-in-acute-coronary-syndromes-a-meta/)
- [Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome](https://scholariq.org/papers/apixaban-with-antiplatelet-therapy-after-acute-coronary-syndrome/)
- [Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study](https://scholariq.org/papers/clinical-presentation-aetiology-and-outcome-of-infective-endocarditis-results-of/)
- [Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals](https://scholariq.org/papers/genomic-and-drug-target-evaluation-of-90-cardiovascular-proteins-in-30-931/)
- [Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial](https://scholariq.org/papers/efficacy-of-apixaban-when-compared-with-warfarin-in-relation-to-renal-function/)
- [The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study](https://scholariq.org/papers/the-novel-biomarker-based-abc-age-biomarkers-clinical-history-bleeding-risk/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)

## Researcher university

- [Uppsala University](https://scholariq.org/institutions/uppsala-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.